>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

  • FND +16.3%, BT +12.4%, FIT +11.6%, SSYS +10.7%, IIVI +10.1%, MOH +9%, NFX +8.9%, ING +8.1%, STAA +7.9%, SNN +7.9%, FORM +6.2%, GNRC +6%, ABMD +5.8%, PGTI +5.6%, ATTU +5.4%, SOI +5.3%, TEVA +5.2%, NVMI +5.1%, FLWS +5%, MTDR +4.9%, LXFR +4.8%, QRVO +4.7%, HPR +4.6%, TS +4.5%, GLOG +4.5%, NXPI +4.3%, DWDP +4.3%, OSB +4.2%, WTI +4%, WRLD +3.7%, APA +3.4%, FRAC +3.4%, CI +2.9%, NTCT +2.9%, OSK +2.8%, NVO +2.4%, CHDN +2.2% (increases annual cash dividend to $1.63/share from $1.52/share, announces 3-for-1 stock split, and a new $300 million share repurchase program; will acquire certain of the ownership interests of Midwest Gaming Holdings, the parent company of Rivers Casino Des Plaines, for aggregate cash consideration of at least $326 million), SU +2.1%, TUSK +2%, AVP +2%, AMCX +2%, O +1.9%, CNQ +1.9%, NEXA +1.8%, KIM +1.4%, WMB +1.3%, MT +1.2%, EC +1%, .

M&A news:

  • HK +19% (to sell all of its water infrastructure assets across the Delaware Basin to a private company for up to $325 mln in cash)
  • NFX +9.3% (to be acquired by Encana (ECA) in an all-stock transaction valued at approximately $5.5 billion)

Other news:

  • NBRV +16.2% (submits NDA to the FDA to seek marketing approval for CONTEPO to treat complicated urinary tract infections)
  • DNLI +12% (to collaborate with Sanofi (SNY) to Develop RIPK1 inhibitors)
  • HRTX +6.7% (announces FDA submission of NDA for HTX-011 for the management of postoperative pain)
  • AMSC +5.8% (American Superconductor and ComEd to install resilient electric grid system in Chicago)
  • ACHC +4.8% (said to be nearing a deal to be acquired by KKR (KKR), according to the NY Post)
  • BHP +2.9% (BHP Billiton to return $10.4 bln to shareholders through off-market buyback and special dividend; completes sale of Onshore US assets to BP)
  • ABBV +1.5% (Roche Hldg's Genentech and Abbvie (ABBV) announced data from Phase III CLL14 study; indicates primary endpoint was met)
  • TSLA +1.1% (tweets that an updated autonomous summon feature wll be ready in ~six weeks) . 

Analyst comments:

  • BBL +3.4% (upgraded to Buy from Hold at Investec)
  • SEAS +2.3% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)
  • SNY +1.3% (upgraded to Equal Weight from Underweight at Barclays)
  • VLO +1.2% (upgraded to Outperform from Neutral at Credit Suisse)